Table 2.

Percentage of live cells positive for respective surface polarization markers within the CTR (n=12), EO- (n=6) and LO-PE (n=5) groups.

Surface polarization marker	CTR (% of live cells)	EO-PE (% of live cells)	LO-PE (% of live cells)
CD11B	22.2 ± 9.6	38.7 ± 16.5	28.8 ± 17.0
CD11C	45.1 ± 14.3	69.9 ± 17.8	51.9 ± 11.8
CD40	17.1 ± 5.9	38.9 ± 12.6	22.6 ± 10.9
CD80	2.9 ± 1.8	6.5 ± 3.5	10.5 ± 8.9
CD86	25.0 ± 10.3 *	41.7 ± 3.6 ‡	21.6 ± 6.8
CD163	89.4 ± 3.9	82.0 ± 4.5	81.8 ± 6.8
CD206	47.6 ± 9.8	33.5 ± 6.5	38.2 ± 13.3
CD209	53.3 ± 6.9 †††	43.7± 12.1 ‡‡	22.1 ± 5.2
TLR1	5. 9 ± 6.2 †	9.5 ± 6.2	18.8 ± 13.6
TLR2	6.1 ± 3.9 *	1.2 ± 1.5	5.4 ± 4.5
TLR4	37.3 ± 12.3 *	79.7 ± 19.9	54.2 ± 18.8
HLA-DR	33.8 ± 14.1 ***	77.9 ± 12.6 ‡‡	44.3 ± 18.7
FR-β	79.2 ± 10.0	77.6 ± 20.7	68.4 ± 15.3

Data are presented as mean ± SD. Statistical significance is represented with *p ≤ 0.05, ***p ≤ 0.001; whereas *CTR vs EO-PE; †p ≤ 0.05, †††p ≤ 0.001; whereas †CTR vs LO-PE; ‡ p ≤ 0.05, ‡‡p ≤ 0.01; whereas ‡EO-PE vs LO-PE, by ANCOVA with Sidak’s post-hoc test and adjustment for gestational age.